Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression

Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression

The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.

Inclusion Criteria:

• Subjects aged 25 to 65 included
• Information and signed informed consent
• Patients with a diagnosis of major depressive episode in remission
• MADRS score between 14 and 22
• Patients with residual symptoms as assessed by MADRS items
• No cognitive impairment.
• Right-handed

Exclusion Criteria:

• Subjects with legal incapacity or limited legal capacity
• Subjects unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
• Pregnant women
• Subjects in the exclusion period of another study or is on the "national volunteer list".
• Subjects with another psychiatric pathology (bipolar mood disorder, psychosis, obsessive-compulsive disorder, addictive pathology, schizophrenia)
• Subjects under a protective measure such as guardianship or safeguard of justice.